Geri
Immuron Limited (IMRN) Fiyatı
IMRN Hisse Senedi Fiyat Grafiği
IMRN Kazanmak
Immuron Limited
$0.98
-1.3%
$-0.01
Kapanışta: Jan 23, 16:00:00 GMT-5
$0.96
-1.62%
$-0.01
Sonrası Piyasa: Jan 23, 20:00:00 GMT-5
Earnings FAQ
IMRN'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Immuron Limited IMRN'ün son çeyrekteki geliri nasıl performans gösterdi?
Immuron Limited'in gelir tahmini nedir?
Immuron Limited'in kazanç kalite puanı nedir?
Immuron Limited kazançlarını ne zaman rapor eder?
Immuron Limited'in beklenen kazançları nelerdir?
Immuron Limited kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.997
Açılış fiyatı
$1.03
Günün Aralığı
$0.968 - $1.03
52 haftalık aralık
$0.677 - $2.39
İşlem hacmi
7.7K
Ort.Hacim
578.7K
EPS (TTM)
-0.61
Dividend yield
--
Piyasa Değeri
$7.8M
Immuron Limited nedir?
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved